Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II multicenter randomized double-blind placebo-controlled trial of chloroquine phosphate gel for high-risk HPV infection
CTR20251747Phase 2Active
- Sponsor
- Capbio
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in human papillomavirus infection, sponsored by Capbio. Started May 2025; status: active.
02
Drugs
chloroquine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on CTR20251747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251747.